« Back
Home /
CXCL8 Polyclonal Antibody

CXCL8 Polyclonal Antibody

Manufacturer	Biomatik
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes Antibodies By Cell Type Carcinoma Immunohistochemistry Western Blot ELISA Primary Antibodies
Type	Antibody Polyclonal
Specific against	Human
Applications	WB, IHC, ELISA
Amount	100ug
Host	Rabbit
Item no.	BM-CAC07046-100ug
Targets	CXCL8;;TUBG1
eClass 6.1	32160702
eClass 9.0	32160702
Available
Immunogen	Recombinant human Interleukin-8 protein (23-99AA)
Conjugate	Unconjugated
Alternative Names	CXCL8, IL8??IL-8??C-X-C motif chemokine 8??Emoctakin??Granulocyte chemotactic protein 1??GCP-1??Monocyte-derived neutrophil chemotactic factor??MDNCF??Monocyte-derived neutroph
UniProt ID	P10145
Purification	Caprylic Acid Ammonium Sulfate Precipitation Purified
Storage Instructions	Aliquot and store at -20C. Minimize freezing and thawing.
Expiry Date	1 year
Shipping Condition	Blue ice
Comment	IL-8 is a chemotactic factor that attracts neutrophils, basophils, and T-cells, but not monocytes. It is also involved in neutrophil activation. It is released from several cell types in response to an inflammatory stimulus. IL-8(6-77) has a 5-10-fold higher activity on neutrophil activation, IL-8(5-77) has increased activity on neutrophil activation and IL-8(7-77) has a higher affinity to receptors CXCR1 and CXCR2 as compared to IL-8(1-77), respectively.
Restriction	For research use only. Not for diagnostic procedures.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100ug

available

Delivery expected until 5/30/2024